文献速递痛风与晶体性关节病

情境因素对痛风患者降尿酸治疗血清尿酸疗效的效应修饰:系统评价与Meta回归分析

Effect modification by contextual factors of urate-lowering therapy on serum urate in people with gout: A systematic review with meta-regression analysis.
PubMed 文献 · Semin Arthritis Rheum · 2022-06-15

该系统评价与Meta回归分析纳入8项随机对照试验,探索年龄、性别、种族、肾功能、心血管合并症、痛风石、噻嗪类利尿剂使用及既往降尿酸治疗等情境因素对降尿酸治疗血清尿酸达标疗效的效应修饰。四项试验(36项随机比较)的肾功能分层数据可汇总分析,结果显示正常、轻度或中度肾功能受损患者接受降尿酸治疗均比对照更可能达标;其他情境因素数据不足。

要点

  • 正常、轻度或中度肾功能受损的痛风患者接受降尿酸治疗比对照更可能达到血清尿酸目标。

核心结论

  • 少数随机对照试验报告了探索情境因素作用的分析;降尿酸治疗似乎在所有肾功能水平均有效达到血清尿酸目标,但重度肾功能受损似乎带来轻微劣势。

研究设计与样本

  • 以(更新的)Cochrane综述中的随机对照试验为起点,纳入探索任何情境因素对痛风患者降尿酸治疗血清尿酸疗效作用的随机对照试验。
  • 对数据充足(即至少3项试验)的情境因素进行混合效应Meta回归分析,试验和比较作为随机效应,特定情境因素作为固定因素建模。
  • 共纳入8项随机对照试验。

主要发现

  • 探索了年龄、性别、种族、肾功能、心血管合并症、痛风石、噻嗪类利尿剂使用及既往降尿酸治疗等情境因素的效应修饰。
  • 按肾功能分层的原始数据来自四项试验(36项随机比较),适合进行Meta分析。
  • 汇总估计显示,肾功能正常、轻度或中度受损的痛风患者接受降尿酸治疗比对照更可能达到血清尿酸目标。
  • 数据不足以就其他情境因素的效应修饰得出结论。

临床怎么用

  • 降尿酸治疗似乎在所有肾功能水平均有效达到血清尿酸目标,但重度肾功能受损似乎带来轻微劣势。
  • 原文未据此给出推荐。

局限性

  • 报告探索情境因素作用的分层分析的随机对照试验很少。
  • 数据不足以就其他情境因素的效应修饰得出结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To synthesize evidence of the effect of contextual factors (CFs) on efficacy of urate-lowering therapy (ULT) on serum urate (SU) as outcome in gout patients. METHODS: Randomised controlled trials (RCTs) from (updated) Cochrane reviews were the starting point. RCTs were included if they explored the role of any CF on efficacy of ULT on SU in gout patients. For CFs with sufficient data (i.e. ≥3 trials), a mixed-effects meta-regression analysis was performed with trial and comparison as random effects, whereas specific CFs were modelled as fixed factors. RESULTS: Eight RCTs were included. Effect modification by CFs was explored for age, sex, race, renal function, cardiovascular comorbidity, tophi, thiazide-diuretic use, and previous ULT use. Crude data stratified by renal function were available for four trials (36 randomised comparisons), and suitable for meta-analysis. Pooled estimates revealed that gout patients with a normal, mildly-, or moderately impaired renal function were consistently more likely to achieve SU target with ULT compared to control. Among RCTs comparing ULT to placebo (30 comparisons), effects of ULT on achieving SU target were not statistically different for those with normal (OR:66.87;[11.39-392.75]) compared to mildly (OR:28.54;[5.11-159.46]) and moderately (OR:21.45;[3.20-143.64]) impaired renal function, but seemed lower in those with severely impaired (OR:9.13;[0.96-86.97]) renal function. Data were insufficient to draw conclusions on effect modification by other CFs. CONCLUSION: Few RCTs report stratified analyses exploring the role of CFs. ULT seemed effective in reaching the SU target in all levels of renal function, though severely impaired renal function appeared to render a slight disadvantage.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Kampe RT, Nielsen SM, Hotea I, et al. Effect modification by contextual factors of urate-lowering therapy on serum urate in people with gout: A systematic review with meta-regression analysis. Semin Arthritis Rheum. 2022. PMID: 35728446. doi:10.1016/j.semarthrit.2022.152049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。